分娩室から新生児集中治療室への移動中の肌と肌の接触:超早産児とその親への影響 (TRANSPAPNEO)
超早産児の分娩室から新生児集中治療室への移送中の肌と肌の接触の評価
Developmental care are recognized as a standard of care for preterm infants in neonatal intensive care units. Regular skin-to skin contacts during the neonatal stay show short and long-term beneficial effects on preterm infants and their parents. Skin-to-skin contact provides hemodynamic and thermal stability in preterm infants. Regarding parents, skin-to-skin contact sustains the parental bonding, and reduces stress and anxiety related to hospitalization. As a result, early skin-to-skin contact has been associated with an improvement of neurological outcome in very preterm infants.
Thermal stability is crucial during the first hour of life in preterm infants. A temperature at admission in the neonatal intensive care unit below 36.5°C or above 37.2°C has been associated with an increase in neonatal morbidity and mortality.
Early skin-to-skin contact between a newborn and his/her mother in the delivery room significantly decreases the occurrence of hypothermia below 35.5°C.
The practice of skin-to-skin transfer from the delivery room is emerging in France. Pilot studies have been carried out by French neonatal teams that showed the feasibility of this practice in late-preterm, near-term and term infants. Although skin-to-skin contact routinely involves very preterm infants in neonatal intensive care units worldwide, the feasibility and safety of skin-to-skin contact during the transfer from delivery room to the neonatal unit is poorly documented in very preterm infants. Previous data of our team showed that transfer of preterm infants with non-invasive ventilation using skin-to-skin contact was feasible and safe but concerns emerged about the thermal conservation during the procedure.
The main hypothesis of this study is that skin-to skin contact during the transfer from the delivery room to the neonatal intensive care unit could prevent heat losses in preterm infants as well as the transfer in incubator. Another hypothesis is that very early skin-to-skin contact could positively influence the neonatal course and the parental experience in the neonatal care unit.
調査の概要
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
-
Angers、フランス、49000
- CHU Angers
-
Orléans、フランス、45000
- Neonatal medicine and intensive care unit, University Hospital, Orléans
-
Toulouse、フランス、31300
- Neonatology service, University Hospital, Toulouse
-
Tours、フランス、37000
- Neonatal and paediatric service, University Hospital, Tours
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Gestational age < 34 weeks
- Singleton pregnancy
- Inborn birth, i.e., in the maternity ward of investigating centres
- Need of hospitalization in the neonatal intensive care unit
- Oral and written information of parents and written parental consent to participate in the study (by the father if the mother is unable to participate)
Exclusion Criteria:
- Single parent or homosexual couple
- Absence of the father in the delivery room
- Parents not speaking French
- Skin temperature of the newborn < 36°C at the time of randomization
- Conditions not allowing the early skin-to-skin contact: omphalocele, gastroschisis, desquamating dermatological conditions (Harlequin syndrome, Collodion)
- Clinical condition requiring a specific transfer mode according to the pediatrician in the delivery room
- Parents under legal protection
- Minor parents
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:他の
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Skin-to-skin contact during the transfer between the delivery room and the neonatal care unit
Preterm infants will be transferred using a direct skin-to-skin contact with their father from the delivery room to the intensive neonatal care. |
For the Skin-to-skin Contact (SSC) transfer, the bare-chested father will seat in a wheelchair. Newborns who will wear only a diaper and a cotton cap or noninvasive ventilation headgear will be placed in the kangaroo position against the father's chest to ensure direct contact with the father's skin. Preterm infants with gestational age less than 33 weeks will be wrapped with their father using plastic bags plus warmed cotton towels. More gestationally mature infants will be wrapped with only warmed cotton wraps. The newborn's heart rate, oxygen saturation and skin temperature will be monitored throughout the procedure. |
|
アクティブコンパレータ:Transfer in incubator between the delivery room and the neonatal care unit
Preterm infants will be transferred in an incubator set to 36°C from the delivery room to the intensive neonatal care. |
In the incubator group, infants will be transferred after resuscitation in an incubator with air temperature set to 36°C. The newborn will be laid on his/her back in a polyethylene bag with a cap. The newborn's heart rate, oxygen saturation and skin temperature will be monitored throughout the procedure. |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change in the infant skin temperature due to the transfer procedure
時間枠:During the transfer procedure
|
Fluctuation in the infant skin temperature between the randomization in the delivery room and the admission in the neonatal intensive care unit (NICU) |
During the transfer procedure
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change in the infant's heart rate during the transfer procedure
時間枠:During the transfer procedure
|
Heart rate values during the transfer procedure |
During the transfer procedure
|
|
Occurrence of bradycardia episodes in infant during the transfer procedure
時間枠:During the transfer procedure
|
Rapid decrease in heart rate less than 100 beats/min that lasts at least 10 secondes during the transfer procedure |
During the transfer procedure
|
|
Change in the infant's oxygen saturation during the transfer procedure
時間枠:During the transfer procedure
|
Oxygen saturation values during the transfer procedure |
During the transfer procedure
|
|
Occurrence of desaturation episodes in infant during the transfer procedure
時間枠:During the transfer procedure
|
Decrease in oxygen saturation less than 85% that last at least 10 secondes |
During the transfer procedure
|
|
Change in the infant's fraction of inspired oxygen during the transfer procedure
時間枠:During the transfer procedure
|
Fraction of inspired oxygen values during the transfer procedure |
During the transfer procedure
|
|
Duration of the transfer procedure
時間枠:During the transfer procedure
|
Time (in min) during the transfer procedure |
During the transfer procedure
|
|
First Hydrogen Potential (pH) of the newborn
時間枠:First blood gas in the NICU
|
First assessment of pH in the neonatal intensive care unit (NICU) |
First blood gas in the NICU
|
|
Carbon dioxide partial pressure (pCO2) of the newborn
時間枠:First blood gas in the NICU
|
First assessment of carbon dioxide partial pressure (pCO2) in the neonatal intensive care unit (NICU) |
First blood gas in the NICU
|
|
Blood glucose of the newborn
時間枠:First blood glucose measurement in the NICU
|
First assessment of blood glucose in the neonatal intensive care unit (NICU) |
First blood glucose measurement in the NICU
|
|
Occurence of hypothermia
時間枠:From admission in the neonatal intensive care unit to 30 min later
|
Decrease of skin temperature less than 36°C |
From admission in the neonatal intensive care unit to 30 min later
|
|
Time to the first skin-to-skin contact in the neonatal care unit
時間枠:Postnatal hour when the first skin-to-skin contact will occur in the neonatal care unit
|
Postnatal hour when the first skin-to-skin contact will occur in the neonatal care unit |
Postnatal hour when the first skin-to-skin contact will occur in the neonatal care unit
|
|
Practice of skin-to-skin contact in the neonatal intensive care unit (NICU) during the first week of life
時間枠:During the first 7 days of the stay in the neonatal care unit
|
Frequency of skin-to-skin contact (Postnatal day and hour), length of each skin-to-skin contact, which parent involves in each skin-to-skin contact episode. |
During the first 7 days of the stay in the neonatal care unit
|
|
Quality of parental bond
時間枠:2 time points: i) Between the infant postnatal day 3 and postnatal day 7, and ii) at the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30
|
Assessment through a maternal questionnaire: Mother-to-Infant Bonding Scale (MIBS) questionnaire (Mother-to-infant bonding scale - Taylor, 2005). Only the infant's mother will be invited to fill out this questionnaire. |
2 time points: i) Between the infant postnatal day 3 and postnatal day 7, and ii) at the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30
|
|
Parental stress
時間枠:2 time points: i) Between the infant postnatal day 3 and postnatal day 7, and ii) at the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30
|
Parental stress assessed by Perceived Stress Scale (PSS) - Neonatal Intensive Care Unit (NICU) questionnaire (Perceived Stress Scale Neonatal Intensive Care Unit - Miles, 1993). The infant's mother and father will be invited to fill out this questionnaire. |
2 time points: i) Between the infant postnatal day 3 and postnatal day 7, and ii) at the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30
|
|
Parental post-traumatic stress disorder
時間枠:At the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30
|
Parental post-traumatic stress disorder assessed by Perinatal Post traumatic stress disorder Questionnaire (PPQ) - DEMIER, 1996). The infant's mother and father will be invited to fill out this questionnaire. |
At the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30
|
|
Infant growth: Weight
時間枠:At birth and weight at the postmenstrual age of 36 weeks
|
Weight at birth and at the postmenstrual age of 36 weeks |
At birth and weight at the postmenstrual age of 36 weeks
|
|
Infant growth: Height
時間枠:At birth and at the postmenstrual age of 36 weeks
|
Height at birth and at the postmenstrual age of 36 weeks |
At birth and at the postmenstrual age of 36 weeks
|
|
Infant growth: Head circumference
時間枠:At birth and at the postmenstrual age of 36 weeks
|
Head circumference at birth and at the postmenstrual age of 36 weeks |
At birth and at the postmenstrual age of 36 weeks
|
|
Neonatal morbidity and mortality at the postmenstrual age of 36 weeks
時間枠:At the postmenstrual age of 36 weeks
|
Death
|
At the postmenstrual age of 36 weeks
|
|
Modalities of breastfeeding
時間枠:During the NICU stay: infant postnatal day
|
First breastfeeding attempt in the neonatal intensive care unit (NICU) |
During the NICU stay: infant postnatal day
|
|
Modalities of breastfeeding
時間枠:At the postmenstrual age of 36 weeks
|
Presence of complete or partial breastfeeding at the postmenstrual age of 36 weeks |
At the postmenstrual age of 36 weeks
|
|
Mode of infant feeding at the postmenstrual age of 36 weeks
時間枠:At the postmenstrual age of 36 weeks
|
Modes of infant feeding that include breastfeeding, breastmilk given through a bottle, artificial formula |
At the postmenstrual age of 36 weeks
|
その他の成果指標
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Self-questionnaires to study parents' experience of their infant hospitalization
時間枠:2 time points: i) Between the infant postnatal day 3 and postnatal day 7, and ii) at the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30
|
Ancillary study: Self-questionnaires to study parents' experience of their infant hospitalization to assess stress at different times. |
2 time points: i) Between the infant postnatal day 3 and postnatal day 7, and ii) at the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30
|
協力者と研究者
捜査官
- スタディディレクター:Nolwenn CLENET、University Hospital, Tours
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。